Literature DB >> 7911710

Determinants of susceptibility to cigarette smoke. Potential roles for neuroendocrine cells and neuropeptides in airway inflammation, airway wall remodeling, and chronic airflow obstruction.

S M Aguayo1.   

Abstract

There is a subgroup of cigarette smokers who are more susceptible than others to the deleterious effects of cigarette smoke and to chronic airflow obstruction. The study of histopathologic and physiologic differences between these "susceptible" smokers and "resistant" smokers, who do not develop clinically significant airflow obstruction, may lead to better understanding of host factors that determine individual susceptibility to cigarette smoke. This report puts forth the hypothesis that individual differences in number or function of pulmonary neuroendocrine cells may play an important role in determining whether cigarette smokers develop chronic airflow obstruction and perhaps other smoking-related disorders. In this context, pulmonary neuroendocrine cells and bombesin-like peptides are discussed, emphasizing those aspects most relevant to the pathobiologic consequences of cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911710     DOI: 10.1164/ajrccm.149.6.7911710

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  14 in total

1.  Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration.

Authors:  S D Reynolds; A Giangreco; J H Power; B R Stripp
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Recurrent wheezing in very preterm infants.

Authors:  D E Elder; R Hagan; S F Evans; H R Benninger; N P French
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

3.  Selective gene expression analysis of the neuroepithelial body microenvironment in postnatal lungs with special interest for potential stem cell characteristics.

Authors:  Line Verckist; Robrecht Lembrechts; Sofie Thys; Isabel Pintelon; Jean-Pierre Timmermans; Inge Brouns; Dirk Adriaensen
Journal:  Respir Res       Date:  2017-05-08

4.  Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease.

Authors:  Marilee J Wick; Erica J Buesing; Carol A Wehling; Zoe L Loomis; Carlyne D Cool; Martin R Zamora; York E Miller; Sean P Colgan; Louis B Hersh; Norbert F Voelkel; Edward C Dempsey
Journal:  Am J Respir Crit Care Med       Date:  2010-09-02       Impact factor: 21.405

Review 5.  The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Authors:  Melissa L Sinkus; Sharon Graw; Robert Freedman; Randal G Ross; Henry A Lester; Sherry Leonard
Journal:  Neuropharmacology       Date:  2015-02-19       Impact factor: 5.250

6.  Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice.

Authors:  Khalid Ashour; Lin Shan; Jong Hwan Lee; William Schlicher; Keiji Wada; Etsuko Wada; Mary E Sunday
Journal:  Am J Respir Crit Care Med       Date:  2006-04-07       Impact factor: 21.405

Review 7.  Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?

Authors:  Michael Roth
Journal:  Drugs       Date:  2015-01       Impact factor: 9.546

Review 8.  Airway inflammation and hypersensitivity induced by chronic smoking.

Authors:  Yu Ru Kou; Kevin Kwong; Lu-Yuan Lee
Journal:  Respir Physiol Neurobiol       Date:  2011-03-10       Impact factor: 1.931

9.  Role of superoxide anions in airway hyperresponsiveness induced by cigarette smoke in conscious guinea pigs.

Authors:  M Nishikawa; M Kudo; N Kakemizu; H Ikeda; T Okubo
Journal:  Lung       Date:  1996       Impact factor: 2.584

10.  Immunohistochemical Detection of Markers for Translational Studies of Lung Disease in Pigs and Humans.

Authors:  David K Meyerholz; Allyn M Lambertz; Leah R Reznikov; Georgina K Ofori-Amanfo; Phil H Karp; Paul B McCray; Michael J Welsh; David A Stoltz
Journal:  Toxicol Pathol       Date:  2015-10-27       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.